Better management strategies are needed for patients with comorbid end-stage COPD and afib.
Your search for comorbidities returned 76 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Using 2 national cohorts 10 years apart, researchers compared the mean age of young adults, who were hospitalized for PVD with CV comorbidities and major adverse cardiac and cerebrovascular events.
Researchers assessed the clinical outcomes of patients with comorbid heart failure and diabetes receiving treatment with metformin and sulfonylurea.
People with pulmonary arterial hypertension display higher levels of depression and anxiety than previously estimated by healthcare workers.
Further studies are needed to understand the effect of smoking cessation on outcomes in patients undergoing transcatheter aortic valve replacement.
Using data on patients with existing atrial fibrillation (AF), researchers analyzed the link between diabetes with the AF phenotype and cardiac and neurologic comorbidities.
The effects of hybrid comprehensive telerehabilitation compared with usual care were analyzed in a cohort of patients with HFrEF.
The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.
Inhaled epoprostenol delivered via high-flow nasal cannula increased oxygenation among patients with severe hypoxemia with pulmonary hypertension or right heart dysfunction.
SAFE-PAD evaluated the real-world safety of femoropopliteal artery revascularization using drug-coated vs non-drug-coated devices.